Literature DB >> 30184562

MetS Risk Score: A Clear Scoring Model to Predict a 3-Year Risk for Metabolic Syndrome.

Tian-Tian Zou1,2, Yu-Jie Zhou1,3, Xiao-Dong Zhou4, Wen-Yue Liu5, Sven Van Poucke6, Wen-Jun Wu5, Ji-Na Zheng1,3, Xue-Mei Gu5, Dong-Chu Zhang7, Ming-Hua Zheng1,8, Xiao-Yan Pan5.   

Abstract

Although several risk factors for metabolic syndrome (MetS) have been reported, there are few clinical scores that predict its incidence. Therefore, we created and validated a risk score for prediction of 3-year risk for MetS. Three-year follow-up data of 4395 initially MetS-free subjects, enrolled for an annual physical examination from Wenzhou Medical Center were analyzed. Subjects at enrollment were randomly divided into the training and the validation cohort. Univariate and multivariate logistic regression models were employed for model development. The selected variables were assigned an integer or half-integer risk score proportional to the estimated coefficient from the logistic model. Risk scores were tested in a validation cohort. The predictive performance of the model was tested by computing the area under the receiver operating characteristic curve (AUROC). Four independent predictors were chosen to construct the MetS risk score, including BMI (HR=1.906, 95% CI: 1.040-1.155), FPG (HR=1.507, 95% CI: 1.305-1.741), DBP (HR=1.061, 95% CI: 1.002-1.031), HDL-C (HR=0.539, 95% CI: 0.303-0.959). The model was created as -1.5 to 4 points, which demonstrated a considerable discrimination both in the training cohort (AUROC=0.674) and validation cohort (AUROC=0.690). Comparison of the observed with the estimated incidence of MetS revealed satisfactory precision. We developed and validated the MetS risk score with 4 risk factors to predict 3-year risk of MetS, useful for assessing the individual risk for MetS in medical practice. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30184562     DOI: 10.1055/a-0677-2720

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

1.  Scoring systems of metabolic syndrome and prediction of cardiovascular events: A population based cohort study.

Authors:  Nima Motamed; Hossein Ajdarkosh; Mohammad Hadi Karbalaie Niya; Mahshid Panahi; Behzad Farahani; Nader Rezaie; Mehdi Nikkhah; Amir H Faraji; Gholamreza Hemmasi; Dhayaneethie Perumal; G Hossein Ashrafi; Fahimeh Safarnezhad Tameshkel; Esmaeel Gholizadeh; Mahmoodreza Khoonsari; Farhad Zamani
Journal:  Clin Cardiol       Date:  2022-04-14       Impact factor: 3.287

Review 2.  Reporting and Methods in Developing Prognostic Prediction Models for Metabolic Syndrome: A Systematic Review and Critical Appraisal.

Authors:  Hui Zhang; Jing Shao; Dandan Chen; Ping Zou; Nianqi Cui; Leiwen Tang; Dan Wang; Zhihong Ye
Journal:  Diabetes Metab Syndr Obes       Date:  2020-12-15       Impact factor: 3.168

3.  Machine learning-aided risk prediction for metabolic syndrome based on 3 years study.

Authors:  Haizhen Yang; Baoxian Yu; Ping OUYang; Xiaoxi Li; Xiaoying Lai; Guishan Zhang; Han Zhang
Journal:  Sci Rep       Date:  2022-02-10       Impact factor: 4.379

4.  Opening the black box: interpretable machine learning for predictor finding of metabolic syndrome.

Authors:  Yan Zhang; Xiaoxu Zhang; Jaina Razbek; Deyang Li; Wenjun Xia; Liangliang Bao; Hongkai Mao; Mayisha Daken; Mingqin Cao
Journal:  BMC Endocr Disord       Date:  2022-08-26       Impact factor: 3.263

5.  Incidence and prediction nomogram for metabolic syndrome in a middle-aged Vietnamese population: a 5-year follow-up study.

Authors:  Tran Quang Thuyen; Dinh Hong Duong; Bui Thi Thuy Nga; Nguyen Anh Ngoc; Duong Tuan Linh; Pham Tran Phuong; Bui Thi Nhung; Tran Quang Binh
Journal:  Endocrine       Date:  2021-08-02       Impact factor: 3.633

6.  Development and Internal Validation of a Prognostic Model for 4-Year Risk of Metabolic Syndrome in Adults: A Retrospective Cohort Study.

Authors:  Hui Zhang; Dandan Chen; Jing Shao; Ping Zou; Nianqi Cui; Leiwen Tang; Dan Wang; Zhihong Ye
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-18       Impact factor: 3.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.